Announcement of the performance for the second quarter of the 2026 fiscal year. Reports figures such as revenue, operating income, ordinary income, and net income, with YoY comparisons. Segment details are unclear (some sections marked as unknown).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4892","jir_company_name":"Cyfuse Biomedical K.K. (Cyfuse Biomedical K.K.)","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4892-20260820-01.pdf","jir_short_summary":"Announcement of the performance for the second quarter of the 2026 fiscal year. Reports figures such as revenue, operating income, ordinary income, and net income, with YoY comparisons. Segment details are unclear (some sections marked as unknown).","jir_summary":"### Overview of results\nThe disclosed earnings materials focus on the financial results for the second quarter of the 2026 fiscal year, presenting year-over-year comparisons for revenue and each profit indicator. The segment breakdown is marked as unknown in the text, suggesting the detailed breakdown may not have been disclosed. Overall, operating loss, ordinary loss, and net loss appear to have persisted, and similar trends may be observed when compared with the previous period. The outlook is not clearly stated in the materials, so further disclosure should be awaited.\n\n### Impact on shareholders and future outlook\nThe disclosed financial indicators suggest deterioration in profitability, so the impact on shareholder value should be evaluated cautiously in the short term. If future disclosures provide the revenue mix for devices and regenerative medicine, progress on cost reductions and capital policy, and medium-to-long-term growth strategies, those will serve as useful material for investment decisions.","jir_financial_highlights":"Revenue: 104,321\uff08\u5358\u4f4d\u4e0d\u660e\u3001PDF\u5185\u306e\u8868\u8a18\u306b\u5f93\u3044\u300c\u4e0d\u660e\u300d\u6271\u3044\uff09 (YoY + Unknown%)\nOperating income: \u25b3417 (YoY + Unknown%)\nOrdinary income: \u25b3433 (YoY + Unknown%)\nNet income: \u25b3434 (YoY + Unknown%)","jir_category":"","jir_hashtags":"#Cyfuse, #Earnings, #FinancialHighlights","jir_key_figures":"Revenue: 104,321\uff08unit: unknown, PDF notation\uff09\nOperating loss: \u25b3471 \u2192 \u25b3417 \u2192 \u25b31,081\uff08multiple notations possible\uff09\nOrdinary loss: \u25b3401 \u2192 \u25b3433\uff08assumed values, notation variance\uff09","jir_meta_title":"\u3010Cyfuse\u30112026 Fiscal Year December Interim Earnings Summary\uff5cRevenue and Profit Highlights","jir_meta_description":"Key points of Cyfuse's 2026 fiscal year second quarter earnings summary. Includes trends in revenue, operating income, ordinary income, and net income, YoY comparison, and whether segment information is provided.","jir_og_title":"Cyfuse's earnings information: Q2 performance trends","jir_og_description":"Outline of Cyfuse's 2026 fiscal year second-quarter earnings highlights, including revenue and profit trends and key takeaways for future outlook.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":59821,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-105795","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n